NCT02310022View on ClinicalTrials.gov

A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

August 31, 2016

Conditions
Hypertriglyceridemia
Interventions
DRUG

Drug Omega 3

4 g (4 capsules) once a day, administered with food

DRUG

Drug Omega-3 Comparator

4 g (4 capsules) once a day, administered with food

Trial Locations (1)

M1S 3V6

Pharma Medica Reserach Inc, Toronto

Sponsors
All Listed Sponsors
lead

Matinas Biopharma, Inc

INDUSTRY